Suchergebnisse - (Person:"Wei, Xiang")

PubPharm (13)

1

Incidence and risk of hypertension associated with ramucirumab in cancer patients : A systematic review and meta-analysis

enthalten in: Journal of cancer research and therapeutics | 2016

von Qi, W. | Fu, S. | Zhang, Q. | +1

2

Bevacizumab increases the risk of infections in cancer patients : A systematic review and pooled analysis of 41 randomized controlled trials

enthalten in: Critical reviews in oncology/hematology | 2015

von Qi, W. | Fu, S. | Zhang, Q. | +1

3

Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer : a meta-analysis of 17 phase III randomized controlled trials

enthalten in: Current medical research and opinion | 2015

von Qi, W. | Fu, S. | Zhang, Q. | +1

4

Incidence and risk of severe infections associated with anti-epidermal growth factor receptor monoclonal antibodies in cancer patients : a systematic review and meta-analysis

enthalten in: BMC medicine | 2014

von Qi, W. | Fu, S. | Zhang, Q. | +1

CommentIn: BMC Med. 2015;13:37. - PMID 25857245

5

Risk of hypertension in cancer patients treated with aflibercept : a systematic review and meta-analysis

enthalten in: Clinical drug investigation | 2014

von Qi, W. | Shen, Z. | Tang, L. | +1

6

Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients : a systematic review and meta-analysis

enthalten in: British journal of clinical pharmacology | 2013

von Qi, W. | He, A. | Shen, Z. | +1

7

Incidence and risk of treatment-related mortality in cancer patients treated with EGFR-TKIs : a meta-analysis of 22 phase III randomized controlled trials

enthalten in: Respiratory medicine | 2013

von Qi, W. | Tang, L. | He, A. | +2

8

Incidence and risk of hypertension with vandetanib in cancer patients : a systematic review and meta-analysis of clinical trials

enthalten in: British journal of clinical pharmacology | 2013

von Qi, W. | Shen, Z. | Lin, F. | +5

9

Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer : a systematic review and meta-analysis of randomized controlled trials

enthalten in: Current medical research and opinion | 2013

von Qi, W. | Shen, Z. | Lin, F. | +5

10

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients : a meta-analysis

enthalten in: PloS one | 2013

von Qi, W. | Huang, Y. | Yao, Y. | +2